May 10 Oncosec Medical Inc
* Oncosec announces clinical collaboration with Merck to evaluate combination of immunopulse IL-12 and keytruda(pembrolizumab) for metastatic melanoma
* Additional details of collaboration were not disclosed
* Says under agreement, Oncosec will sponsor and fund study and Merck will provide keytruda Source text for Eikon: Further company coverage:
REFILE-India's Infosys says reassessing long-term goals due to tougher market
Bengaluru, June 24 Infosys Ltd, India's second-biggest software services exporter, is re-evaluating its long-term targets because tougher market conditions have made them appear "daunting", the company's chairman said on Saturday.
WORLD NEWS SCHEDULE AT 1400 GMT/10 AM ET
Iraqi forces free hundreds of civilians in Mosul Old City battles as death toll mounts